Steris | STE - Assets


Steris reported $10.74B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
3M USD 35.44B 2.3B Mar/2026
Accuray USD 448.01M 8.81M Dec/2025
Avanos Medical USD 1.05B 23.6M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
CONMED USD 2.31B 10.81M Mar/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
Ecolab USD 25.04B 344.3M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Fortive USD 11.58B 153.6M Mar/2026
Getinge SEK 63.92B 4.3B Dec/2024
Globus Medical USD 5.44B 136.79M Mar/2026
Haemonetics USD 2.4B 94.96M Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Olympus JPY 1.54T 79.24B Mar/2026
Orthofix International USD 886.6M 35.95M Mar/2026
Owens Minor USD 2.42B 35.78M Mar/2026
ResMed USD 8.78B 280.91M Mar/2026
Steris USD 10.74B 145.8M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026